arabinofuranosyluracil has been researched along with Acute Liver Injury, Drug-Induced in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Dixon, D; Fallon, JK; Liu, J; Mosedale, M; Nautiyal, M; Qasem, RJ; Smith, PC; Wolf, KK | 1 |
Amberntsson, S; Andersson, LC; Cairns, J; Chouhan, B; Darnell, M; Ewart, L; Foster, AJ; Hamilton, GA; Jang, KJ; Kodella, K; Lazic, SE; Morgan, P; Petropolis, DB; Regan, SL; Rollison, H; Rubins, JE; Srivastava, A; Williams, D | 1 |
Bell, CC; Dankers, AC; Ellis, E; Fredriksson Puigvert, L; Goldring, CE; Hendriks, DF; Ingelman-Sundberg, M; Jacobs, F; Jenkins, RE; Kitteringham, NR; Lauschke, VM; Mkrtchian, S; Moro, SM; Nordling, Å; Park, BK; Renblom, A; Sison-Young, RL; Snoeys, J; Walsh, J | 1 |
Marwick, C | 2 |
Stone, R | 1 |
Marshall, E | 1 |
Gaffey, MJ; Hoofnagle, JH; Kleiner, DE; McKenzie, R; Nichols, L; Sallie, R; Straus, SE; Tsokos, M | 1 |
8 other study(ies) available for arabinofuranosyluracil and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Characterization of primary mouse hepatocyte spheroids as a model system to support investigations of drug-induced liver injury.
Topics: Acetaminophen; Adenosine Triphosphate; Albumins; Animals; Arabinofuranosyluracil; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Female; Hepatocytes; Male; Mice, Inbred C57BL; Models, Biological; Phenylacetates; Proteomics; Spheroids, Cellular; Sulfonamides; Tolvaptan; Transcriptome | 2021 |
Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid.
Topics: Acetaminophen; Arabinofuranosyluracil; Biomarkers; Cell Culture Techniques; Cell Survival; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Glutathione Transferase; Hepatocytes; Humans; Liver; Models, Biological; Spheroids, Cellular | 2019 |
Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease.
Topics: Arabinofuranosyluracil; Cells, Cultured; Chemical and Drug Induced Liver Injury; Hepatocytes; Humans; Models, Biological; Proof of Concept Study; Proteome; Spheroids, Cellular | 2016 |
IOM panel exonerates researchers in FIAU deaths.
Topics: Antiviral Agents; Arabinofuranosyluracil; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drugs, Investigational; Humans; Liver Diseases; Malpractice; National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; United States | 1995 |
Panel clears NIH in patient deaths.
Topics: Antiviral Agents; Arabinofuranosyluracil; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Humans; National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; National Institutes of Health (U.S.); United States; United States Food and Drug Administration | 1995 |
NIH panel report of 'no flaws' in FIAU trial at variance with FDA report, new probe planned.
Topics: Antiviral Agents; Arabinofuranosyluracil; Cause of Death; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Hepatitis B; Hepatitis, Chronic; Humans; Liver Diseases; National Institutes of Health (U.S.); Scientific Misconduct; United States; United States Food and Drug Administration | 1994 |
Hepatitis study. Drug trial deaths deemed unavoidable.
Topics: Antiviral Agents; Arabinofuranosyluracil; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Federal Government; Government Regulation; Hepatitis B; Humans; National Institutes of Health (U.S.); Pancreatic Diseases; Research Subjects; United States; United States Food and Drug Administration | 1994 |
Histopathologic changes associated with fialuridine hepatotoxicity.
Topics: Adult; Antiviral Agents; Arabinofuranosyluracil; Chemical and Drug Induced Liver Injury; Chronic Disease; Clinical Trials, Phase II as Topic; Female; Hepatitis B; Humans; Liver; Male; Middle Aged; Randomized Controlled Trials as Topic | 1997 |